← Leaderboards
Timothy N Bullock
University Of Virginia Charlottesville
$7,542,914
Attributed
$11,097,570
Total exposure
8
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2005–23$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$11,097,570 · 8
By mechanism
R01$8,820,577 · 4
RC2$1,000,000 · 1
K01$640,240 · 1
R21$382,635 · 1
R56$254,118 · 1
Top collaborators
- Richard J Price9 shared
- Victor H. Engelhard5 shared
- Dean H Kedes2 shared
Most similar at University Of Virginia Charlottesville
Same institution · by research overlap
- Lukas K Tamm$22,130,390
- Victor H. Engelhard$22,896,814
Others in their field
Top investigators on “Melanoma”
- David Heimbrook · Leidos Biomedical Research, Inc.$206,517,726
- Richard L Schilsky · University Of Chicago$108,377,382
- Larry Arthur$59,113,709
- Charles A Coltman · Southwest Oncology Group$55,198,633
- Robert L Comis · Frontier Sci &Technology Rsch Fdn, Inc$47,956,689
- Meenhard Herlyn · University Of Pennsylvania$46,448,742
Research focus
MelanomaResponseTumorCellsT-LymphocyteImmunotherapyMediatingAntigensDesignBaseInfiltrationAntibodiesOutcome ForecastCd8b1 GeneBloodExhibitsCancer ImmunotherapyImmuneSurfacePlayImmune ResponseTumor GrowthMemoryCytokine
Grant awards (31)
Focused Ultrasound Regimens that Synergize with Melanoma Immunotherapy$662,209
R01 · FY2023 · EB
Focused Ultrasound Regimens that Synergize with Melanoma Immunotherapy$662,209
R01 · FY2022 · EB
Focused Ultrasound Regimens that Synergize with Melanoma Immunotherapy$648,963
R01 · FY2021 · EB
Focused Ultrasound Regimens that Synergize with Melanoma Immunotherapy$675,709
R01 · FY2020 · EB
Leveraging MR-Guided Focused Ultrasound to Potentiate Immunotherapy for GBM$208,881
R21 · FY2020 · CA · contact PI
Immunotherapeutic Nanoparticle Delivery to Melanoma With MR-Guided Focused Ultrasound$500,099
R01 · FY2019 · CA
Leveraging MR-Guided Focused Ultrasound to Potentiate Immunotherapy for GBM$173,754
R21 · FY2019 · CA · contact PI
Immunotherapeutic Nanoparticle Delivery to Melanoma With MR-Guided Focused Ultrasound$517,432
R01 · FY2018 · CA
BLIMP-1 mediated regulation of CD8+ TIL$686,810
R01 · FY2017 · CA · contact PI
Immunotherapeutic Nanoparticle Delivery to Melanoma With MR-Guided Focused Ultrasound$519,263
R01 · FY2017 · CA
BLIMP-1 mediated regulation of CD8+ TIL$686,810
R01 · FY2016 · CA · contact PI
Immunotherapeutic Nanoparticle Delivery to Melanoma With MR-Guided Focused Ultrasound$521,056
R01 · FY2016 · CA
BLIMP-1 mediated regulation of CD8+ TIL$50,481
R01 · FY2016 · CA · contact PI
Immunotherapeutic Nanoparticle Delivery to Melanoma With MR-Guided Focused Ultrasound$537,316
R01 · FY2015 · CA
BLIMP-1 mediated regulation of CD8+ TIL$365,178
R01 · FY2015 · CA · contact PI
BLIMP-1 mediated regulation of CD8+ TIL$326,220
R01 · FY2015 · CA · contact PI
BLIMP-1 mediated regulation of CD8+ TIL$72,734
R01 · FY2015 · CA · contact PI
BLIMP-1 mediated regulation of CD8+ TIL$316,433
R01 · FY2014 · CA · contact PI
BLIMP-1 mediated regulation of CD8+ TIL$43,539
R01 · FY2014 · CA · contact PI
BLIMP-1 mediated regulation of CD8+ TIL$306,001
R01 · FY2013 · CA · contact PI
Strategies for Therapeutic Vaccination Against KSHV$500,000
RC2 · FY2010 · CA
Strategies for Therapeutic Vaccination Against KSHV$500,000
RC2 · FY2009 · CA
CD70 Mediated Costimulation of T Cell Responses$254,118
R56 · FY2008 · CA · contact PI
CD70 mediated costimulation of T cell responses$247,420
R01 · FY2007 · CA · contact PI
CD70 mediated costimulation of T cell responses$233,745
R01 · FY2006 · CA · contact PI
The role of CD4+ T cells in melanoma immunotherapy$137,068
K01 · FY2006 · CA · contact PI
CD70 mediated costimulation of T cell responses$240,950
R01 · FY2005 · CA
The role of CD4+ T cells in melanoma immunotherapy$134,648
K01 · FY2005 · CA
The role of CD4+ T cells in melanoma immunotherapy$132,300
K01 · FY2004 · CA
The role of CD4+ T cells in melanoma immunotherapy$130,019
K01 · FY2003 · CA
The role of CD4+ T cells in melanoma immunotherapy$106,205
K01 · FY2002 · CA